Will regenerative medicine replace transplantation?

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 8, 2013, Pages

  Orlando, Giuseppe ^a   Soker, Shay ^a   Stratta, Robert J ^a   Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOENGINEERING; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; QUALITY OF LIFE; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

BIOENGINEERING; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; QUALITY OF LIFE; REGENERATIVE MEDICINE; TISSUE ENGINEERING; WAITING LISTS;

EID: 84881083800     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015693     Document Type: Article

References (51)

1. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. 2006. Tissue-engineered autologous bladders for patients needing cys-toplasty. Lancet 367: 1241-1246.
2. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. 2012. Engineered whole organs and complex tissues. Lancet 379: 943-952.
3. Baiguera S, Birchall MA, Macchiarini P. 2010. Tissue-engineered tracheal transplantation. Transplantation 89: 485-491.
4. Baptista PM, Siddiqui MM, Lozier G, Rodriguez SR, Atala A, Soker S.2011. The useof whole organ decellularization for the generation of a vascularized liver organoid. Hep-atology 53: 604-617.
5. Barakat O, Abbasi S, Rodriguez G, Rios J, Wood RP, Ozaki C, Holley LS, Gauthier PK. 2012. Use of decellularized porcine liver for engineering humanized liver organ. J Surg Res 173: e11-e25.
6. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, et al. 2012. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35: 1436-1445.
7. Bissell MJ, Hall HG, Parry G. 1982. How does the extracellular matrix direct gene expression? J Theor Biol 99: 31-68.
8. Chung SY, Krivorov NP, Rausei V, Thomas L, Frantzen M, Landsittel D, Kang YM, Chon CH, Ng CS, Fuchs GJ. 2005. Bladder reconstitution with bone marrow derived stem cells seededon small intestinal submucosa improves morphological and molecular composition. J Urol 174: 353-359.
9. Dantal J, Soulillou JP. 2005. Immunosuppressive drugs and the riskofcancerafterorgan transplantation.NEngJMed 352: 1371-1373.
10. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP. 1998. Effect of long-term immu-nosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens. Lancet 351: 623-628.
11. Dharnidharka VR, Stablein DM, Harmon WE. 2004. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transpl 4: 384-389.
12. Elliott MJ, De Coppi P, Speggiorin S, Roebuck D, Butler CR, Samuel E, Crowley C, McLaren C, Fierens A, Vondrys D, et al. 2012. Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. Lancet 380: 994-1000.
13. Filipponi F, Pisati R, Cavicchini G, Ulivieri MI, Ferrara R, Mosca F. 2003. Cost and outcome analysis and cost determinants of liver transplantation in a European national health service hospital. Transplantation 275: 1731-1736.
14. Folkman J, Hochberg M. 1973. Self-regulation of growth in three dimensions. J Exp Med 138: 745-753.
15. Galbraith CA, Hathaway D. 2004. Long-term effects of transplantation on quality of life. Transplantation 77: S84-S87.
16. Hammond JS, Gilbert TW, Howard D, Zaitoun A, Micha-lopoulos G, Shakesheff KM, Beckingham IJ, Badylak SF. 2011. Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol 54: 279-287.
17. Hata T, Uemoto S, Fujimoto Y, Murakami T, Tateno C, Yoshizato K, Kobayashi E. 2012. Transplantation of engineered chimeric liver with autologous hepatocytes and xenobiotic scaffold. Ann Surg 257: 542-547.
18. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T. 2010. Late-term results of tissue- engineered vascular grafts in humans. J Thorac Cardio-vasc Surg 139: 431-436.
19. Ivanov PP. 1937. Obshchaia i sravnitel'naia embriologiia. Moscow-Leningrad.
20. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozo'ky B, Crowley C, Einarsson O, Grinnemo KH, Gudbjartsson T, et al. 2011. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocompo-site: A proof-of-concept study. Lancet 378: 1997-2004.
21. Karam VH, Gasquet I, Delvart V, Hiesse C, Dorent R, Danet C, Samuel D, Charpentier B, Gandjbakhch I, Bismuth H, et al. 2003. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 76: 1699-1704.
22. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, et al. 2008. Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023-2030.
23. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, et al. 2009. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: A multicentre cohort study. Lancet 373: 1440-1446.
24. Meguid El, Nahas A, Bello AK. 2005. Chronic kidney disease: The global challenge. Lancet 365: 331-334.
25. Mertsching H, Schanz J, Steger V, Schandar M, Schenk M, Hansmann J, Dally I, Friedel G, Walles T. 2009. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation 88: 203-210.
26. Ng SL, Narayanan K, Gao S, Wan AC. 2011. Lineage restricted progenitors for the repopulation of decellularized heart. Biomaterials 32: 7571-7580.
27. Olausson M, Patil PB, Kuna VK, Chougule P, Hernandez N, Methe K, Kullberg-Lindh C, Borg H, Ejnell H, Sumitran-Holgersson S. 2012. Transplantation of an allogeneic vein bioengineered with autologous stem cells: A proof-of-concept study. Lancet 380: 230-237.
28. Orlando G. 2010. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Expert Rev Clin Immunol 6: 879-892.
29. Orlando G, Soker S, Wood K. 2009. Clinical operational tolerance after liver transplantation. J Hepatol 50: 1247-1257.
30. Orlando G, Hematti P, Stratta RJ, Burke GW, Di Cocco P, Pisani F, Soker S, Wood KJ. 2010a. Clinical operational tolerance after renal transplantation: Current status and future challenges. Ann Surg 252: 913-926.
31. Orlando G, Stratta RJ, Light J. 2010b. Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant 16: 110-115.
32. Orlando G, Wood KJ, Soker S, Stratta RJ. 2011a. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation 92: e36-e38.
33. Orlando G, Wood KJ, Stratta RJ, Yoo J, Atala A, Soker S. 2011b. Regenerative medicine and organ transplantation: Past, present and future. Transplantation 91: 1310-1317.
34. Orlando G, Farney A, Sullivan DC, Abouschwareb T, Iskan-dar S, Wood KJ, Atala A, Stratta RJ, Yoo JJ, Soker S. 2012a. Production and implantation of renal extracellular ma-trix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg 256: 363-370.
35. Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, et al. 2012b. Regenerative medicine as applied to general surgery. Ann Surg 255: 867-880.
36. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. 2008. Perfusion-decellularized matrix: Using nature's platform to engineera bioartificial heart. Nat Med 14: 213-221.
37. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L, Kotton D, Vacanti JP. 2010. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16: 927-933.
38. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. 1997. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349: 990-993.
39. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, et al. 2010. Tissue-engineered lungs forinvivo implantation. Science 29: 538-541.
40. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. 2001. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385-386.
41. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. 2010. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 363: 147-155.
42. Rauh J, Milan F, Günther KP, Stiehler M. 2011. Bioreactor systems for bone tissue engineering. Tissue Eng PartB Rev 17: 263-280.
43. Romagnoli G, De Luca M, Faranda F, Bandelloni R, Franzi AT, CataliottiF,CanceddaR. 1990. Treatmentof posterior hypospadias by the autologous graft of cultured urethral epithelium. N Engl J Med 323: 527-530.
44. Ross EA, Williams MJ, Hamazaki T, Terada N, Clapp WL, Adin C, Ellison GW, Jorgensen M, Batich CD. 2009. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 20: 2338-2347.
45. Shinoka T, Imai Y, Ikada Y. 2001. Transplantation of atissue-engineered pulmonary artery. N Engl J Med 344: 532-533.
46. Soto-Gutierrez A, Zhang L, Medberry C, Fukumitsu K, Faulk D, Jiang H, Reing J, Gramignoli R, Komori J, Ross M, et al. 2011. Awhole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 17: 677-686.
47. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, Milwid J, Kobayashi N, Tilles A, Ber-thiaume F, et al. 2010. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16: 814-820.
48. Wainwright JM, Czajka CA, Patel UB, Freytes DO, Tobita K, Gilbert TW, Badylak SF. 2010. Preparation of cardiac extracellular matrix froman intact porcine heart. Tissue Eng Part C Methods 16: 525-532.
49. Wang Y, Cui CB, Yamauchi M, Miguez P, Roach M, Mala-varca R, Costello MJ, Cardinale V, Wauthier E, Barbier C, et al. 2011. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 53: 293-305.
50. Warnke PH, Springer IN, Wiltfang J, Acil Y, Eufinger H, Wehmöller M, Russo PA, Bolte H, Sherry E, Behrens E, et al. 2004. Growth and transplantation of a custom vas-cularised bone graft in a man. Lancet 364: 766-770.
51. Yagi H, Fukumitsu K, Fukuda K, Kitago M, Shinoda M, Obara H, Itano O, Kawachi S, Tanabe M, Coudriet GM, et al. 2012. Human-scale whole-organ bioengineering for liver transplantation: A regenerative medicine approach. Cell Transplant 22: 231-242.